MACQUARIE GROUP LTD - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 169 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.93 and the average weighting 0.2%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$465,000
-36.2%
146,7790.0%0.00%0.0%
Q2 2023$729,000
+0.6%
146,7790.0%0.00%0.0%
Q1 2023$725,000
-21.5%
146,7790.0%0.00%0.0%
Q4 2022$923,000
-42.4%
146,779
-0.4%
0.00%
-50.0%
Q3 2022$1,603,000
-5.3%
147,372
-0.7%
0.00%0.0%
Q2 2022$1,692,000
+25.1%
148,4690.0%0.00%
+100.0%
Q1 2022$1,352,000
-39.0%
148,4690.0%0.00%
-50.0%
Q4 2021$2,215,000
-41.9%
148,469
+0.1%
0.00%
-33.3%
Q3 2021$3,812,000
-1.4%
148,3290.0%0.00%0.0%
Q2 2021$3,868,000
-26.1%
148,3290.0%0.00%
-57.1%
Q1 2021$5,236,000
+39.4%
148,329
-0.3%
0.01%
+40.0%
Q4 2020$3,756,000
-33.1%
148,7830.0%0.01%
-44.4%
Q3 2020$5,611,000
-11.9%
148,7830.0%0.01%
-18.2%
Q2 2020$6,371,000
+123.3%
148,783
+1.4%
0.01%
+83.3%
Q1 2020$2,853,000
-25.2%
146,7790.0%0.01%
+20.0%
Q4 2019$3,813,000
-4.7%
146,7790.0%0.01%
-28.6%
Q3 2019$4,000,000
-66.2%
146,779
-66.7%
0.01%0.0%
Q2 2019$11,823,000
+178.6%
440,337
+200.0%
0.01%0.0%
Q1 2019$4,243,000
+7.3%
146,7790.0%0.01%
-12.5%
Q4 2018$3,953,000146,7790.01%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$5,700,1778.82%
Wildcat Capital Management, LLC 1,920,787$6,088,8952.44%
TPG GP A, LLC 18,716,306$59,330,6901.02%
EcoR1 Capital, LLC 4,488,200$14,227,5940.48%
CROSSPOINT FINANCIAL, LLC 12,000$38,0400.40%
Coastal Bridge Advisors, LLC 406,847$1,289,7050.35%
CAXTON ASSOCIATES LP 480,104$1,521,9300.21%
Woodline Partners LP 5,313,915$16,845,1110.20%
Rhenman & Partners Asset Management AB 300,000$951,0000.10%
Navalign, LLC 75,365$238,9070.09%
View complete list of ALLOGENE THERAPEUTICS INC shareholders